RASEF

Across TCGA pan-cancer cohorts, RASEF mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RASEF’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where RASEF mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types RASEF is over-expressed in tumor.

LUAD and CCRCC are the cancer types where RASEF tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RASEF mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	II,III,IV	+0.436	<.001	8	view →
CCRCC	All	All	+0.733	.044	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RASEF–LUAD

Open the LUAD breakdown →